Antitrust Antitrust

Merck unit's Spanish dominance-abuse fine inflated for deterrent effect, decision shows

By Tono Gil
  • 02 Nov 2022 15:21
  • 02 Nov 2022 15:21
Merck Sharp & Dohme received a higher fine for abuse of dominance than intended by Spanish antitrust enforcers after an intervention by their authority's executive board, according to the full infringement decision.
The shift in direction shows the authority’s ambition to send a tough message on dominance abuse by pharmaceutical

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Tono Gil

Regulatory Reporter

Tono is a competition reporter for MLex in Brussels. Prior to joining MLex, he worked as a trainee in the European Parliament and as a correspondent in Valencia and Buenos Aires for the Spanish news agency EFE. Tono holds a degree in Journalism from the University of Valencia and a master in Transmedia Journalism.

Discover MLex

Stay on top of global regulatory developments

Latest News